Related Experiment Video
Updated: Dec 29, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer
Fei Han1, Wen-bin Liu1, Jian-jun Li2
1Institute of Toxicology, College of Preventive Medicine
Abstract:
The authors and journal apologize for errors in the above paper, which appeared in volume 26 part 3, pages 303–319. The errors relate to the legend of Fig. 1A on page 307 and the artwork of Fig. 8D on page 316:
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020